Achaogen
About Us
Company Overview
Our Focus
Our Culture
Management Team
Board of Directors
Scientific Advisory Board
Product
Pipeline
Pipeline Overview
C-Scape
Monoclonal Antibody Program
Novel Aminoglycosides
Our Approach to R&D
Scientific Publications
Investors
Investor Overview
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Contact Us
Careers
Overview
Values
Benefits
Positions Available
Fellowship
Contact Us
About Us
/
Company Overview
Our Focus
Our Culture
Management Team
Board of Directors
Scientific Advisory Board
Product
/
Pipeline
/
Pipeline Overview
C-Scape
Monoclonal Antibody Program
Novel Aminoglycosides
Our Approach to R&D
Scientific Publications
Investors
/
Investor Overview
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Contact Us
Careers
/
Overview
Values
Benefits
Positions Available
Fellowship
Contact Us
/
/
Media
About Us
/
Company Overview
Our Focus
Our Culture
Management Team
Board of Directors
Scientific Advisory Board
Product
/
Pipeline
/
Pipeline Overview
C-Scape
Monoclonal Antibody Program
Novel Aminoglycosides
Our Approach to R&D
Scientific Publications
Investors
/
Investor Overview
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Contact Us
Careers
/
Overview
Values
Benefits
Positions Available
Fellowship
Contact Us
/
/
Media Archive
Press Releases
Scientific Publications
See more press releases
Media
Comparison of Plazomicin MIC Test Strip and Broth Microdilution MIC Results for 125 Enterobacteriaceae
about 2 weeks ago
Comparative Activity of Plazomicin and Other Aminoglycosides against Enterobacteriaceae Isolates from Various Infection Sources from Hospitalized Patients in the United States
about 2 weeks ago
Microbiological Outcomes With Plazomicin Versus Meropenem in Patients With Complicated Urinary Tract Infections, Including Acute Pyelonephritis, in the EPIC Study
about 2 weeks ago
See more scientific publications
